JDS sells Lithobid for bipolar disorder and Pexeva for depression, panic disorder and obsessive-compulsive disorder. It has applied to market the capsule ...
New York-based JDS sells the branded prescription psychiatry drugs Lithobid and Pexeva, which are used to treat bipolar disorder and depression, ...
JDS markets two prescription psychiatry products, Pexeva and Lithobid, and has a pipeline of psychiatry and women's health treatments that includes one ...
Looking ahead to the second half of 2007, Noven expects net sales of Pexeva and Lithobid of $14 million and the company would recognize approximately $12 ...